IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 158 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 2.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $12,056,000 | +1.1% | 781,339 | -1.8% | 0.27% | +8.0% |
| Q4 2017 | $11,927,000 | +5.0% | 795,659 | +10.5% | 0.25% | +1.2% |
| Q3 2017 | $11,355,000 | -8.8% | 720,069 | +9.2% | 0.25% | -6.8% |
| Q2 2017 | $12,452,000 | +22.5% | 659,509 | +10.7% | 0.26% | +20.5% |
| Q1 2017 | $10,165,000 | +7.2% | 595,835 | -4.0% | 0.22% | +2.3% |
| Q4 2016 | $9,485,000 | +53.0% | 620,345 | +58.9% | 0.21% | +81.4% |
| Q3 2016 | $6,200,000 | +21.4% | 390,435 | 0.0% | 0.12% | +15.7% |
| Q2 2016 | $5,105,000 | +26.4% | 390,435 | +5.8% | 0.10% | +27.5% |
| Q1 2016 | $4,038,000 | – | 369,085 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |